| Variable | Variable description | Data type | Visibility | Categories (if any) | Category description |
| Country | Name of country with mass campaigns for ITN distribution | Text | Public | ||
| WHO region | Regions identified by the WHO | Drop-down (one option) | Public | African region | |
| Americas region | |||||
| South-East Asia region | |||||
| European region | |||||
| Eastern mediterranean region | |||||
| Western Pacific region | |||||
| Initial campaign year | Calendar year campaign initially would take place, stated in year As stated in Global Fund grant, PMI MOP or other plans. |
Drop-down (one option) | Public | Pending submission of data | |
| 2024 | |||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| Current campaign year | Calendar year campaign will take place according to latest updates, stated in year | Drop-down (one option) | Public | Pending submission of data | |
| 2024 | |||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| Geographic target | Geographic target refers to the specific geographic areas or regions targeted for the campaign as well as how the distribution method will be executed. “National” indicates targeting at the level of the entire country, while “Sub-national” indicates targeting at a more localized level, such as specific regions, districts, or communities within the country. The ITN campaign rollout strategy outlines how the distribution methods for ITN will be executed. “Single-phase” distribution indicates that all ITNs are distributed at once, while “multi-phase” involves multiple stages of distribution over time (e.g. pilot distribution first and then remaining targeted areas). A “rolling distribution” is used for countries that continuously have campaigns every year to cover the country. |
Drop-down (one option) | Public | National – one phase | |
| National – multi-phases | |||||
| National – rolling distribution | |||||
| Sub-national – one phase | |||||
| Sub-national – multi phases | |||||
| Sub-national – rolling distribution | |||||
| Unknown | |||||
| Geographic scope (Provinces, States, Regions) | Disaggregated data or information by states, province, or region where available | Text | Public | ||
| Geographic scope (district, county, LGA) | Disaggregated data or information by district (or equivalent) level where available | Text | Public | ||
| Population targeted | Number of people targeted for the mass ITN campaign disaggregated to sub-national levels if available | Number | Public | ||
| # of ITNs planned | ITNs planned for the campaign based on national malaria programme information, RBM gap analysis or other sources. | Number | Public | ||
| ITN type | Type of ITN planned | Drop-down (multiple choice) | Public | Dual AI | |
| PBO | |||||
| Standard ITN | |||||
| Unknown | |||||
| Net brand (hidden) |
Brand of the ITN (not publicly disclosed on the AMP website) | Drop-down (multiple choice) | Not public | DuraNet LN | Company: Shobikaa Impex Private Limited | Active Ingredient/Synergist: Alpha-cypermethrin |
| DuraNet Plus | Company: Shobikaa Impex Private Limited | Active Ingredient/Synergist: Alpha-cypermethrin, Piperonyl Butoxide (PBO) | ||||
| GreenNet | Company: Shobikaa Impex Private Limited | Active Ingredient/Synergist: Deltamethrin | ||||
| Interceptor | Company: BASF AGRO B.V. Arnhem (NL) Freienbach Branch | Active Ingredient/Synergist: Alpha-cypermethrin | ||||
| Interceptor G2 | Company: BASF AGRO B.V. Arnhem (NL) Freienbach Branch | Active Ingredient/Synergist: Alpha-cypermethrin, Chlorfenapyr | ||||
| MAGNet | Company: V.K.A. Polymers Pvt. Ltd | Active Ingredient/Synergist: Alpha-cypermethrin | ||||
| MiraNet | Company: AtoZ Group Limited | Active Ingredient/Synergist: Alpha-cypermethrin | ||||
| OLYSET Net | Company: Sumitomo Chemical Co., Ltd | Active Ingredient/Synergist: Permethrin | ||||
| OLYSET PLUS | Company: Sumitomo Chemical Co., Ltd | Active Ingredient/Synergist: Permethrin, Piperonyl Butoxide (PBO) | ||||
| Panda Net 2.0 | Company: Life Ideas Biotechnology Co. Ltd | Active Ingredient/Synergist: Deltamethrin | ||||
| PermaNet 2.0 | Company: Vestergaard Sarl | Active Ingredient/Synergist: Deltamethrin | ||||
| PermaNet 3.0 | Company: Vestergaard Sarl | Active Ingredient/Synergist: Deltamethrin, Piperonyl Butoxide (PBO) | ||||
| PermaNet Dual | Company: Vestergaard Sarl | Active Ingredient/Synergist: Chlorfenapyr, Deltamethrin | ||||
| PRONet Duo | Company: V.K.A. Polymers Pvt. Ltd | Active Ingredient/Synergist: Bifenthrin, Chlorfenapyr | ||||
| Reliefnet Reverte | Company: Real Relief Health ApS | Active Ingredient/Synergist: Deltamethrin | ||||
| Royal Guard | Company: Mainpol GmbH | Active Ingredient/Synergist: Alpha-cypermethrin, Pyriproxyfen | ||||
| Royal Sentry 2.0 | Company: Mainpol GmbH | Active Ingredient/Synergist: Alpha-cypermethrin | ||||
| SafeNet | Company: Mainpol GmbH | Active Ingredient/Synergist: Alpha-cypermethrin | ||||
| SAFENET PLUS | Company: Mainpol GmbH | Active Ingredient/Synergist: Alpha-cypermethrin, Piperonyl Butoxide (PBO) | ||||
| Tsara Boost | Company: PPP Hollandi DMCC | Active Ingredient/Synergist: Deltamethrin, Piperonyl Butoxide (PBO) | ||||
| Tsara Plus | Company: PPP Hollandi DMCC | Active Ingredient/Synergist: Deltamethrin, Piperonyl Butoxide (PBO) | ||||
| Tsara Soft | Company: PPP Hollandi DMCC | Active Ingredient/Synergist: Deltamethrin | ||||
| UNET G1 LN | Company: Sino Africa Medical Devices Company Ltd | Active Ingredient/Synergist: Deltamethrin | ||||
| UNET G3 LN | Company: Sino Africa Medical Devices Company Ltd | Active Ingredient/Synergist: Deltamethrin, Piperonyl Butoxide (PBO) | ||||
| UNET G5 LN | Company: Sino Africa Medical Devices Company Ltd | Active Ingredient/Synergist: Alpha-cypermethrin, Chlorfenapyr | ||||
| VEERALIN | Company: V.K.A. Polymers Pvt. Ltd | Active Ingredient/Synergist: Alpha-cypermethrin, Piperonyl Butoxide (PBO) | ||||
| Yahe LN | Company: Fujian Yamei Industry & Trade Co. Ltd | Active Ingredient/Synergist: Deltamethrin | ||||
| Yorkool G1 LN | Company: Tianjin Yorkool International Trading Co., Ltd | Active Ingredient/Synergist: Deltamethrin | ||||
| Yorkool G3 LN | Company: Tianjin Yorkool International Trading Co., Ltd | Active Ingredient/Synergist: Deltamethrin, Piperonyl Butoxide (PBO) | ||||
| Yorkool G5 LN | Company: Tianjin Yorkool International Trading Co., Ltd | Active Ingredient/Synergist: Alpha-cypermethrin, Chlorfenapyr | ||||
| Unknown | |||||
| Funding partner (procurement) | Partner(s) responsible for financing the procurement of ITNs | Drop-down (one option) | Public | AMF | Against malaria foundation |
| Global Fund | |||||
| Government | |||||
| Multiple | |||||
| US state department (formerly PMI) | previously known as PMI | ||||
| Islamic Development Bank (IDP) | |||||
| Givewell | |||||
| Other | |||||
| Unknown | |||||
| Funding partner (implementation) | Partner(s) responsible for financing the implementation of the distribution of ITNs | Drop-down (multiple choice) | Public | AMF | Against malaria foundation |
| Global Fund | |||||
| Government | |||||
| US state department (formerly PMI) | previously known as PMI | ||||
| UNDP | |||||
| SANRU | |||||
| International Dispensary Association (IDA) Foundation | |||||
| Population Services International (PSI) | |||||
| World Bank | |||||
| Islamic Development Bank (IDP) | |||||
| Givewell | |||||
| Other | |||||
| Unknown | |||||
| Funding & ITN procurement | Status of the funding and procurement process for ITNs, including whether a funding application is in progress, approved, or ITNs have been procured. | Drop-down (one option) | Not public | Preparing application | |
| Funding requested | |||||
| Funding approved | |||||
| ITNs procured | |||||
| Other | |||||
| Unknown | |||||
| ITN Delivery status to country | Status of the ITN distribution process, i.e. whether ITNs have been ordered, received, or are still awaiting delivery to country. | Drop-down (one option) | Not public | Pending ITN arrival | |
| Delivered in-country | |||||
| Other | |||||
| Unknown | |||||
| ITN projected arrival date in-country | Planned date of ITN arrival in-country. | Date (month year) | Not public | ||
| Distribution strategy | Strategy adopted for ITN distribution | Drop-down (one option) | Public | Door to door | Distribution teams go from house to house to directly distribute ITNs to residents. |
| Fixed distribution sites | Designated sites such as health centers, schools, or other community locations are set up where beneficiaries can go to receive their ITNs. | ||||
| Hybrid approach | A combination of distribution strategies. For example, a distribution campaign might start with door-to-door distribution in scattered rural areas, followed by fixed distribution sites in urban or densely populated areas. | ||||
| Unknown | |||||
| Initial date planned for distribution (Month Year) | Planned date for start of campaign activity in month/year as stated in GF grant, PMI MOP or other. | Date (month YEAR) | Not public | ||
| Current date planned for distribution (Month Year) | Latest updated planned date for start of campaign activity in month/year. | Date (month YEAR) | Public | ||
| Delay of net distribution (# months) | Represents the difference in months between the Initial planned date and the Current planned date for net distribution. | Automated | Public | ||
| Current campaign phase | The current campaign phase refers to the planning and/or implementation situation, based on the most recent information.
Country view: Displays the phase reported for subnational levels where available (eg district or region). |
Drop-down (one option) | Public | Planned/Not started | Campaign planning has not yet started |
| Macroplanning | Defining the strategy for all campaign technical areas and developing key documents, timeline and budget (operations, M&E, logistics, social and behaviour change, etc.) | ||||
| Microplanning | Updating the macroplans for each district targeted for the campaign with information from decentralized levels to reflect actual context for implementation | ||||
| Implementation | Ongoing trainings, household registration, ITN distribution or other campaign processes | ||||
| On hold | Campaign planning and/or implementation is temporarily paused or cannot proceed as currently planned. | ||||
| Complete | All campaign processes and ITN distribution have been successfully completed | ||||
| Reprogrammed | The campaign will not be implemented as originally planned. Activities or commodities have been reprogrammed to alternative delivery channels, geographic areas, or target populations within the same funding period. | ||||
| Unknown | Data is currently unavailable | ||||
| Campaign status | Campaign status is a measure of the progress of the campaign activities according to the initial or revised timeline.
Status is primarily reported by the National Malaria Programme (NMP) and/or in-country partners based on planned timelines, current phase of implementation, reported delays, and identified bottlenecks. |
Drop-down (one option) + colour coded | Public | On track | The campaign is on track to take place in the same calendar year initially planned/there are no significant bottlenecks identified as of the last report date that would move the campaign off track compared to the revised timeline. |
| At risk | Some risk that the campaign will run into delays/not take place in calendar year planned; a situation not yet critical but important to watch and ensure that the bottlenecks do not grow and move the country off-track to the initial or revised timeline | ||||
| Off track | Significant concerns and campaign at risk of significant delay/not taking place in the calendar year planned; intervention required to address bottlenecks and move country planning back to on track | ||||
| Complete | All campaign processes and ITN distribution have been successfully completed | ||||
| Planned/Not started | Campaign is planned but data has not yet been finalised or are estimations. | ||||
| Cancelled | The campaign will not be implemented as originally planned within the current campaign year or funding cycle. Activities, commodities, targets, or delivery channels may be reprogrammed, reassigned, or delivered through alternative mechanisms, and the original campaign plan will not reach completion. | ||||
| Unknown | Data is currently unavailable | ||||
| Status reasons | Additional information or elaboration regarding the current status of the campaign. | Drop-down (multiple choice) | Public | Delayed ITN delivery | Cases where ITNs are delayed in production, shipping, or customs clearance, preventing timely arrival of ITNs into the country. Includes situations of incomplete deliveries, incorrect quantities, or damaged stock. Excludes in-country storage and dispatch (captured under Planned activities). |
| Funding request/disbursement delay | Situations where financial resources are not yet available to the campaign implementers because of pending or delayed processing of fund requests or disbursements. Includes internal review/approval processes, administrative bottlenecks, or delayed transfer of funds. |
||||
| Funding / ITN / coordination gap | Cases where campaign timelines are affected by pending alignment across partners (e.g., government, implementing partner, donor, procurement agent). Includes delays in sign-offs, approvals, or agreement on operational modalities. |
||||
| Planned activities behind schedule | When campaign preparatory activities (e.g., procurement, training, microplanning, supervision, logistics arrangements) are not yet completed or are behind schedule. Includes pending availability of training materials, delayed microplanning validation, or incomplete staff deployment. |
||||
| Digitalization delay | Situations where readiness of digital tools/platforms (DHIS2, dashboards, electronic data collection tools) is causing postponement of activities. Includes delays in configuration, testing, user training, or equipment deployment. |
||||
| Major national activity (census, elections, …) | Situations where a major national activity restrict the implementation of ITN campaigns (census, elections, political campaigns, …) | ||||
| Public health campaign | Conflicting and uncoordinated other health campaign delays the ITN mass campaign distribution. | ||||
| Operational context / changes | Situations where recent or ongoing events disrupt safe access or program operations. This can include severe weather, natural disasters, infrastructure damage, conflict, violence, or public health emergencies. It covers destruction of roads, inaccessibility of areas, or unsafe conditions that impede campaign planning or implementation. | ||||
| Other | |||||
| Not applicable | For cases where the campaign status is “green / on track.” | ||||
| Key issues on campaign status (hidden) |
Additional information or elaboration regarding the current status of the campaign, not visible to users on the AMP website. | text | Not public | ||
| Comment on campaign status (visible on website) |
Provide additional information or details regarding the status, specifically to be placed on the website. Only needed when status is at risk, off track or delayed. If the campaign dates have been revised, they will be noted here. |
text | Public | ||
| Month distribution took place | Specific month during which the distribution of the ITNs is completed. | Date (month YEAR) | Public | ||
| # of ITNs distributed (hidden) | Total count of ITNs that have been distributed (not publicly disclosed on the AMP website) | number | Not public | ||
| Campaign digitalization | Indicates the extent to which campaign processes and components are digitized | Drop-down (one option) | Public | None (paper-only) | |
| Targeted components | |||||
| Hybrid (paper+digital) | |||||
| Fully digitalized | |||||
| Unknown | |||||
| Scale of digital data collection | Scale of the deployment of the digital data collection | Text | Public | National level | |
| Sub-national level | |||||
| Pilot | |||||
| No digitalization | |||||
| Unknown | |||||
| Platform used | Digital platform in use | Drop-down (one option) | Public | IASO – Bluesquare | |
| Commcare (Dimagi) | |||||
| DIGIT-HCM (eGov) | |||||
| DHIS2 | |||||
| Kobo/ODK | |||||
| Redrose | |||||
| Reveal | |||||
| eCHIS | |||||
| Bespoke/custom | |||||
| Other (specify in comments) | |||||
| No digitalization | |||||
| Unknown | |||||
| Integration | Integration refers to the coordination between different components within the National Malaria Control Program both internally and externally. Internally, integration involves the alignment between interventions such as Seasonal Malaria Chemoprevention (SMC), Indoor Residual Spraying (IRS), and Malaria Vaccine programs. Externally, integration refers to the NMCP’s coordination with other health programs like the Expanded Program on Immunization (EPI), Neglected Tropical Diseases (NTDs), and Vitamin A supplementation initiatives. | Drop-down (one option) | Public | Internal NMP – SMC, IRS, Malaria vaccine, Other | |
| External NMP- EPI, NTDs, Vit A, Other | |||||
| No integration | |||||
| Unknown | |||||
| AMP providing technical assistance | Indicates whether the AMP (Alliance for Malaria Prevention) is providing technical assistance (TA) to support the national malaria programme during the specified campaign year. | Drop-down (one option) | Public | ||
| Last updated (date) | Date the main data source was last updated | Date (DD-MM) | Public | ||
| Comment | Provide additional information or details regarding the status. Any status reasons no longer applicable will be noted here for tracking reasons. | text | Not public |